As marijuana products become more accessible than ever before, the number of cannabis consumers grows worldwide. However, as the market expands, many are unable to identify the major differences or similarities between strains such as cannabis sativa and cannabis indica. This uncertainty is largely due to the disparity between public knowledge and current research. Although the sativa and indica strains are among the most recognizable in the marijuana market, research around benefits and effects is comparatively limited to other substances. Several experts believe that the stigma against marijuana research is due to the plant’s federal Schedule 1 status as an allegedly dangerous and addictive drug.
On September 14, 2021, the Center for Disease Control (“CDC”) and the U.S. Food and Drug Administration (“FDA”) warranted federal warnings against the usage and marketing of Delta-8 THC. In similar reports, these federal agencies warned against the use of Delta-8 because of the lack of research on the rare cannabinoid and the growing accessibility of these products in the market.
On June 1st, 2021, Dave Clark, Amazon’s CEO Worldwide Consumer, announced the company’s new corporate drug testing policies. The global conglomerate’s modified policies are part of Jeff Bezos’ “Earth’s Best Employer and Earth’s Safest Place to Work” initiative to improve Amazon’s working conditions.
As the hemp industry continues with the delta-8 THC craze, another minor cannabinoid is beginning to see market prevalence. THC-O-acetate, commonly referred to as THC-O or ATHC, has also been referred to as the “spiritual cannabinoid,” with some users likening the effect to psilocybin when ingested. Currently, there is a dearth of clinical research regarding efficacy, dosage, and benefits of THC-O.
On June 28, 2021, the Mexican Supreme Court voted in an 8-3 ruling in favor of the decriminalization of marijuana. This ruling comes after Congress stalled a decision over cannabis legalization for over three years. The Mexican Supreme Court’s monumental ruling exerts pressure on the Mexican Congress to vote on cannabis legalization. If approved by Congress, Mexico would become the largest cannabis market in the world. Below, we outline the history behind this controversial matter and dissect what it means for the marijuana industry as a whole.
On July 14, 2021, Senate Majority Leader Chuck Schumer announced draft legislation to decriminalize marijuana at the federal level. This historic legislation proposition was presented by Senator Chuck Schumer, Senator Cory Booker (D-N.Y.), and Senator Ron Wyden (D-Ore). These senators announced the draft legislation while focusing on social justice reforms the bill would sponsor.
Senator Schumer further stated that he would leverage his position as majority leader to make this legislation a top priority in the Senate, as cannabis is already legal in 19 states.
Below, we break down what this historical draft legislation entails and examine the history of cannabis prohibition in the United States.
On June 22, 2021, Governor Ned Lamont signed legislation that would make recreational marijuana legal in Connecticut as of July 1, 2021. With this landmark bill, Connecticut takes substantial steps towards reparations for those most affected by prohibition. New Hampshire and Rhode Island are now the only states in New England to criminalize recreational marijuana. With the passing of this bill, Connecticut becomes the 19th state to legalize recreational marijuana for adults in the United States. Below, we break down what this critical piece of legislation entails.
On March 18, 2021, the Secure and Fair Enforcement (“SAFE”) Banking Act was reintroduced in the U.S. House of Representatives by Rep. Ed Perlmutter (D-CO). On April 19 (just before 4/20), the House approved the legislation again; this time by a vote of 321-101, which also includes a majority of voting Republicans. This reintroduction presents yet another opportunity for the cannabis community, and with a Democratic majority now in the Senate, the chances that this bill gets passed have significantly increased. Below, we take a closer look at the SAFE Banking Act to refamiliarize and reiterate its critical points and examine what this could mean for the hemp and cannabis industries.
Toward the end of the year, business owners and executives analyze their end-of-year finances to determine the company’s success, as well as how employees should be compensated. Many marijuana and hemp employers utilize their profits to give some of their more essential employees, such as initial team members or transitional employees with substantial connections or irreplaceable expertise, extra pay for their hard work. Owners typically do this with cash bonuses or equity-based compensation. As a hemp business owner, it is critical to understand each of these compensation methods before making a choice. Below, we break down your primary considerations.
After several years of failed attempts and efforts, New Jersey finally legalized marijuana on Monday, February 22, 2021, when Governor Philip D. Murphy signed three bills into law. These bills permit and regulate the use of recreational marijuana in the Garden State (with some strict stipulations) and focus on community outreach for previous marijuana-related convictions. The legalization of marijuana in New Jersey comes after a long run of unsuccessful attempts and hopes to end the era of arrests and ambiguity. Below, we take a closer look at New Jersey’s path to legalization of marijuana, as well as the recently enacted legislation itself.